LAKEWOOD, Colo.--(BUSINESS WIRE)--Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, has entered into a business relationship with Kaneka, a global leader in life science products, to gain market authorization in the United States for the use of the Terumo BCT Spectra Optia® Apheresis System with the Kaneka Liposorber® LA-40S LDL Adsorption Column for cardiologists treating patients with high cholesterol.
Help employers find you! Check out all the jobs and post your resume.
